Sign in

CIK 0001018735 · Accelerated filer

NYMOX PHARMACEUTICAL CORP

Sign in to watch
Ticker
NYMXF
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Entity type
other
Phone
1-800-936-9669
Business address
9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT, QUEBEC CANADA, Quebec, Canada, H4M 2V2
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 6-K Event Report of Foreign Issuer
  4. 6-K Event Report of Foreign Issuer
  5. 4 Insider Changes in Ownership
  6. SC 13D Stake Beneficial Ownership Report
  7. 6-K Event Report of Foreign Issuer
  8. 6-K Event Report of Foreign Issuer
  9. EFFECT Other Notice of Effectiveness
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. 6-K Event Report of Foreign Issuer
  12. F-3/A Offering F-3/A
  13. UPLOAD Other SEC-generated Letter
  14. 6-K Event Report of Foreign Issuer
  15. 6-K Event Report of Foreign Issuer
  16. F-3 Offering F-3
  17. 6-K Event Report of Foreign Issuer
  18. 6-K Event Report of Foreign Issuer
  19. 6-K Event Report of Foreign Issuer
  20. 20-F Report Annual and Transition Report of Foreign Private Issuers

Page 12 of 21 · 408 filings